Resources: Cancer care during the coronavirus pandemic

The coronavirus pandemic is changing not only the delivery of cancer care. It’s also changing the reasoning applied to individual clinical scenarios.

The current evidence landscape for COVID-19 in patients with cancer is limited. But various groups have offered guidance based on consensus and available information.

To make it easier to monitor how cancer care is evolving, our clinical oncology leadership has collected guidance from some of the world’s leading health care and oncology organizations.

Updated: Tuesday, May 12, 2020


Summaries on cancer care during the coronavirus pandemic

Increasingly, health care publications and providers are publishing summaries about the care of cancer patients in the face of the pandemic.

Resources on COVID-19-adjusted cancer treatment approaches

Numerous professional cancer care societies have released helpful resources on adjusting cancer treatment during the pandemic.

Guidelines for testing patients with cancer for SARS-Co-V2

Providers and academic medical journals are publishing guidelines on how to test for coronavirus among patients with cancer.   

Resources on delivering palliative care during the COVID-19 pandemic

Leading palliative care organizations are sharing resources and insights on caring for patients with advanced illness during the pandemic.

Resources on managing clinical trials during the COVID-19 pandemic

On the regulatory side, major institutions have released guidance on managing clinical trials during this pandemic:

Treatment adjustments oncologists are considering

As the COVID-19 pandemic progresses, oncologists around the world are considering significant changes to how they treat cancer.

Some of these adjustments include:

  • Using active surveillance when possible
  • Relying on the least immunosuppressive treatment when clinically appropriate
  • Prescribing oral regimens when feasible to enhance social distancing
  • Extending treatment intervals when clinically appropriate
  • Deferring imaging studies when clinically appropriate
  • Conducting visits via telemedicine when clinically appropriate

We will continue to update this resource center as new guidance, resources, and evidence emerge on how to safely and appropriately treat cancer care during the pandemic.

Note: The resources, guidance, and treatment adjustments listed above do not constitute medical advice and/or medical care and do not guarantee results or outcomes. They are not a substitute for the experience and judgment of a physician or other health care professionals. AIM disclaims all responsibility for any consequences or liability attributable or related to any use, nonuse, or interpretation of information contained in these resources listed above.